Disease_category,Disease,Protein,Protein_definition,Method,Nb_SNP,OR[95%CI],P_value
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SHISA5,Protein shisa-5,Inverse variance weighted,16,1.04 [0.63-1.72],0.881383001068973
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,8,0.84 [0.52-1.36],0.479862193695417
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IL12A_IL12B,Interleukin-12,Inverse variance weighted,57,1.07 [0.93-1.22],0.339279770218825
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,16,1.18 [0.88-1.58],0.276801343291128
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,22,1.13 [0.94-1.37],0.19701475207216
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1.13 [0.79-1.62],0.491107321714725
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,36,1.20 [0.98-1.47],0.0792996295658197
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IL18BP,Interleukin-18-binding protein,Inverse variance weighted,13,0.85 [0.57-1.27],0.41878270737383
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,22,0.86 [0.74-1.00],0.052887251366598
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,28,0.87 [0.72-1.05],0.157108980626912
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LMNB2,Lamin-B2,Inverse variance weighted,9,0.98 [0.53-1.80],0.947771932225179
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,Inverse variance weighted,40,1.14 [0.91-1.42],0.249121290791168
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,11,1.18 [0.76-1.81],0.462214345470192
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,13,0.89 [0.64-1.24],0.492364414019878
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,13,1.10 [0.75-1.60],0.627844288788451
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",RNASET2,Ribonuclease T2,Inverse variance weighted,25,1.15 [0.97-1.36],0.0997059696792218
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,Inverse variance weighted,37,0.91 [0.80-1.03],0.135162736253691
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,26,0.94 [0.79-1.13],0.526863356740638
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,Wald ratio,1,0.73 [0.26-2.05],0.548045722525101
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ADGRE1,Adhesion G protein-coupled receptor E1,Inverse variance weighted,35,1.04 [0.88-1.23],0.658787241858973
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,19,1.04 [0.86-1.26],0.703755076791251
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SCARB2,Lysosome membrane protein 2,Inverse variance weighted,17,0.88 [0.66-1.19],0.414828208463565
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,10,0.88 [0.60-1.30],0.530987703873302
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SEMA7A,Semaphorin-7A,Inverse variance weighted,25,0.84 [0.65-1.10],0.205628130210821
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,22,0.98 [0.71-1.36],0.908620940234941
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LGALS9,Galectin-9,Inverse variance weighted,39,1.04 [0.87-1.23],0.661542578552881
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ZBTB17,Zinc finger and BTB domain-containing protein 17,Inverse variance weighted,2,0.72 [0.12-4.36],0.718616085506703
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,27,1.03 [0.85-1.23],0.793844512442776
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,50,0.98 [0.88-1.09],0.733775593037704
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,15,1.17 [0.81-1.67],0.39800640187935
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,36,1.03 [0.86-1.23],0.731594908587899
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD86,T-lymphocyte activation antigen CD86,Inverse variance weighted,25,1.25 [0.98-1.59],0.0681220856654416
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PTPRC,Receptor-type tyrosine-protein phosphatase C,Inverse variance weighted,15,0.81 [0.52-1.27],0.363814085951692
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,17,1.01 [0.81-1.26],0.940268387021018
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,15,1.21 [0.71-2.06],0.485764205994664
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,45,1.19 [1.00-1.42],0.054788933853949
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",B2M,Beta-2-microglobulin,Inverse variance weighted,7,0.97 [0.38-2.45],0.942489312774711
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD72,B-cell differentiation antigen CD72,Inverse variance weighted,13,0.98 [0.66-1.46],0.922319333813971
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,15,1.02 [0.69-1.50],0.930475057106136
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.00 [0.66-1.51],0.984761269351303
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",KLRK1,NKG2-D type II integral membrane protein,Inverse variance weighted,32,1.03 [0.87-1.22],0.692907325484032
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,11,0.99 [0.58-1.70],0.975174184849595
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,25,1.24 [1.01-1.52],0.0390223703233404
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD48,CD48 antigen,Inverse variance weighted,32,1.10 [0.96-1.26],0.15828064295592
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,10,0.84 [0.63-1.11],0.219760676687027
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,39,1.04 [0.84-1.29],0.710202851431541
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IL12B,Interleukin-12 subunit beta,Inverse variance weighted,63,1.07 [0.94-1.22],0.305414477780293
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,15,0.97 [0.73-1.31],0.862149622317239
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",STC1,Stanniocalcin-1,Inverse variance weighted,11,0.83 [0.57-1.21],0.328342716016365
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD7,T-cell antigen CD7,Inverse variance weighted,12,0.94 [0.79-1.12],0.49947001806526
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ICAM3,Intercellular adhesion molecule 3,Inverse variance weighted,33,0.99 [0.79-1.24],0.912213004401888
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",EFNA4,Ephrin-A4,Inverse variance weighted,5,0.49 [0.26-0.93],0.0298786701411942
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CCL3,C-C motif chemokine 3,Inverse variance weighted,15,0.91 [0.72-1.16],0.460992024790246
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",RRM2,Ribonucleoside-diphosphate reductase subunit M2,Wald ratio,1,0.28 [0.05-1.60],0.154009078349113
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",BCL2,Apoptosis regulator Bcl-2,Inverse variance weighted,5,1.02 [0.20-5.27],0.980123311850989
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SWAP70,Switch-associated protein 70,Inverse variance weighted,4,1.17 [0.66-2.07],0.601410798309376
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,5,1.39 [0.37-5.29],0.626852338876736
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",BLNK,B-cell linker protein,Inverse variance weighted,5,1.05 [0.58-1.88],0.878258003311653
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD70,CD70 antigen,Inverse variance weighted,39,1.06 [0.92-1.23],0.409086675992035
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,29,0.99 [0.84-1.16],0.884722961763672
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PSAP,Prosaposin,Inverse variance weighted,13,1.25 [0.95-1.66],0.113039377997515
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,24,1.21 [0.97-1.52],0.0858308379593917
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,5,1.37 [0.34-5.53],0.662559645098771
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD27,CD27 antigen,Inverse variance weighted,18,1.00 [0.78-1.27],0.982709537633574
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD22,B-cell receptor CD22,Inverse variance weighted,31,1.33 [1.04-1.69],0.0247887181894879
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,17,1.14 [0.78-1.67],0.490985273063478
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,15,1.06 [0.80-1.41],0.664968268477688
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD83,CD83 antigen,Inverse variance weighted,19,1.20 [0.89-1.63],0.235836689668786
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SERPINA9,Serpin A9,Inverse variance weighted,26,0.92 [0.82-1.04],0.179532746374594
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,26,0.83 [0.68-1.01],0.0600199129872035
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",DLL1,Delta-like protein 1,Inverse variance weighted,13,1.19 [0.83-1.72],0.34284486700284
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,18,0.98 [0.74-1.29],0.88409137694301
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,19,1.06 [0.82-1.36],0.653491448440509
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",FCRLB,Fc receptor-like B,Inverse variance weighted,65,0.94 [0.84-1.05],0.294700579511426
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,18,1.15 [0.92-1.44],0.215160260678058
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,27,1.08 [0.79-1.48],0.624901999227026
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,15,1.28 [0.90-1.84],0.171391956311317
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IL6,Interleukin-6,Inverse variance weighted,6,1.08 [0.67-1.75],0.753243843777053
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PGF,Placenta growth factor,Inverse variance weighted,8,1.53 [0.82-2.83],0.180332816591333
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SLAMF6,SLAM family member 6,Inverse variance weighted,5,1.31 [0.88-1.95],0.184109024697054
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",DCTPP1,dCTP pyrophosphatase 1,Inverse variance weighted,6,1.67 [0.68-4.12],0.262185990520092
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CCL21,C-C motif chemokine 21,Inverse variance weighted,19,1.02 [0.71-1.45],0.92606936081485
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TCOF1,Treacle protein,Inverse variance weighted,2,0.43 [0.12-1.53],0.19088467477373
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.50 [0.28-0.90],0.0212918239197108
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",FCRL1,Fc receptor-like protein 1,Inverse variance weighted,50,1.19 [0.99-1.44],0.0627995644044912
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CR2,Complement receptor type 2,Inverse variance weighted,42,0.91 [0.73-1.14],0.41641173584199
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CLSTN3,Calsyntenin-3,Inverse variance weighted,8,0.68 [0.34-1.33],0.257633365127506
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IFNLR1,Interferon lambda receptor 1,Inverse variance weighted,9,1.05 [0.84-1.30],0.679642915693557
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,29,1.14 [0.96-1.35],0.126937108554575
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",FCRL3,Fc receptor-like protein 3,Inverse variance weighted,46,1.06 [0.96-1.16],0.251061292387384
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IL18,Interleukin-18,Inverse variance weighted,42,1.00 [0.85-1.17],0.991553528355436
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IL10,Interleukin-10,Inverse variance weighted,5,0.72 [0.46-1.11],0.137562829323473
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PDCD1,Programmed cell death protein 1,Inverse variance weighted,24,1.04 [0.78-1.39],0.795118039934491
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,1.55 [0.70-3.43],0.275694019257693
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CLEC12A,C-type lectin domain family 12 member A,Inverse variance weighted,22,0.99 [0.80-1.22],0.902974965785627
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1.12 [0.56-2.22],0.749145631459346
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",EBI3_IL27,Interleukin-27,Inverse variance weighted,37,1.08 [0.91-1.28],0.403484045337173
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SLAMF8,SLAM family member 8,Inverse variance weighted,28,1.02 [0.92-1.12],0.73747671924565
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,40,1.00 [0.88-1.14],0.994788263000423
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",GZMA,Granzyme A,Inverse variance weighted,20,1.23 [0.72-2.07],0.44736003730162
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CXCL13,C-X-C motif chemokine 13,Inverse variance weighted,2,0.44 [0.13-1.46],0.177831939431497
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,9,1.59 [0.97-2.61],0.0648906477302976
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",FCRL2,Fc receptor-like protein 2,Inverse variance weighted,66,1.06 [0.93-1.21],0.402417548183119
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,12,1.34 [0.96-1.87],0.0846820823504426
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD300E,CMRF35-like molecule 2,Inverse variance weighted,36,0.93 [0.77-1.13],0.466515478841597
